Skip to main content

OncoMethylome to Use BioTrove's Nanoplates to Develop Cancer Biomarkers

NEW YORK (GenomeWeb News) — OncoMethylome will use BioTrove’s OpenArray PCR screening technology to develop gene-methylation cancer biomarkers, BioTrove said today.
 
Terms of the multi-year supply agreement call for BioTrove to provide its OpenArray nanoplates and instruments to help OncoMethylome study and develop DNA methylation-based biomarkers, BioTrove said.
 
OncoMethylome focuses on detecting cancer cells and using PCR tests to predict their response to treatments.
 
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.